$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

자궁내막 염증에 대한 지엽적 에스트로겐 및 프로게스테론 매개 수용체의 역할
Roles of Local Estrogen and Progesterone Mediated Receptors in the Regulation of Endometrial Inflammation 원문보기

생명과학회지 = Journal of life science, v.33 no.1, 2023년, pp.102 - 113  

민계식 (경상국립대학교 간호대학 간호학과)

초록
AI-Helper 아이콘AI-Helper

본 총설에서는 지난 수년 동안 자궁내막 염증 관련 새롭게 밝혀진 에스트로겐프로게스테론 수용체의 기능 중 지엽적 에스트로겐의 합성, 특이적 에스트로겐 수용체의 조절, 프로게스테론 저항성 그리고 스테로이드 호르몬의 작용에 의한 자궁내막 조직세포의 염증반응, 분화 및 생존에 대한 세포 및 분자적 조절기전들을 고찰한다. 자궁내막 조직 기질세포의 비정상적인 후성유전체적 변화는 자궁내막증의 발병과 진행에 중요한 요인으로 작용한다. 특히, 에스트로겐 수용체 유전자들의 차별적 메틸화는 기질세포내 ERα로부터 ERβ로의 발현 우세도 전환을 유도하여, ERβ-매개 염증반응, 프로게스테론 저항성 및 레티노이드 합성장애 등의 비정상적인 에스트로겐 반응을 초래한다. 이 기질세포는 또한 PGE2 및 SF-1 매개에 의한 스테로이드 합성효소의 발현유도를 통하여 지엽적 에스트로겐의 생성을 촉진하며, 증가된 에스트라디올은 다시 ERβ에 피드백으로 작용하여 COX-2 촉진을 통한 염증반응의 악순환을 야기한다. 높은 ERβ의 발현은 중간엽 줄기세포염색질 구조변화릉 야기하여 프로게스테론 저항성을 획득하고, 이는 반복적 생리에 따른 지속적 노출로 자궁내막 조직의 염증을 형성하며, 이후에는 ERβ-매개 에스트로겐과 TNF-α 및 TGF-β1을 포함한 염증 유발 인자들이 작용하여 염증 조직세포의 부착, 혈관생성 및 생존과 기질세포의 분화조절장애를 유도한다. 따라서, 생리주기의 역동적인 호르몬 변화와 이에 따르는 자궁내막 조직의 핵수용체 신호전달 조절기전에 대한 구체적인 이해는 정상적인 생식기능을 유지하면서 자궁내막증과 같은 비정상적 염증질환을 치료하기 위한 새로운 안목을 제공할 수 있을 것으로 기대된다.

Abstract AI-Helper 아이콘AI-Helper

This review discusses the cellular and molecular mechanisms by which the endometrial estrogen and progesterone receptors regulate local estrogen production, expression of the specific estrogen receptors, progesterone resistance, inflammatory responses and the differentiation and survival of endometr...

주제어

표/그림 (6)

AI 본문요약
AI-Helper 아이콘 AI-Helper

성능/효과

  • 결론적으로, 자궁내 및 자궁외 자궁내막조직에서 발생하는 자궁내막증은 비정상적인 후성유전체적 변화, 과잉의 에스트로겐 생성과 ERβ의 과발현으로 활성화되는 염증반응, 프로게스테론 저항성과 그에 따른 레티노이드 합성결핍으로 인한 지엽적인 활성형 에스트로겐의 가용성 증대 그리고 자궁내막 기질 중간엽 줄기세포의 발현조절 장애 등에 기인한 것으로 사료된다

후속연구

  • 이러한 비정상적인 현상들은 결국 기질세포의 분화조절 장애, 세포부착, 혈관생성, 염증심화 및 세포사멸 억제에 따른 생존증가 등의 생물학적 결과를 초래한다. 그러므로, 생리주기의 역동적인 호르몬 변화와 이에 따르는 자궁내막 조직의 핵수용체 신호전달 조절기전에 대한 구체적인 이해는 정상적인 생식기능을 유지하면서 자궁내막증과 같은 비정상적 염증질환을 치료하기 위한 새로운 안목을 제공할 수 있을 것으로 기대된다.
본문요약 정보가 도움이 되었나요?

참고문헌 (92)

  1. Afshar, Y., Hastings, J., Roqueiro, D., Jeong, J. W., Giu- dice, L. C. and Fazleabas, A. T. 2013. Changes in eutopic endometrial gene expression during the progression of experimental endometriosis in the baboon, Papio anubis. Biol. Reprod. 88, 44. 

  2. Alexander, I. E., Clarke, C. L., Shine, J. and Sutherland, R. L. 1989. Progestin inhibition of progesterone receptor gene expression in human breast cancer cells. Mol. Endocrinol. 3, 1377-1386. 

  3. Altintas, D., Kokcu, A., Kandemir, B., Tosun, M. and Cetinkaya, M. B. 2010. Comparison of the effects of raloxifene and anastrozole on experimental endometriosis. Eur. J. Obstet. Gynecol. Reprod. Biol. 150, 84-87. 

  4. Anglesio, M. S., Papadopoulos, N., Ayhan, A., Nazeran, T. M., Noe, M., Horlings, H. M., Lum, A., Jones, S., Senz, J., Seckin, T., Ho, J., Wu, R-C., Lac, V., Ogawa, H., Tessier-Cloutier, B., Alhassan, R., Wang, A., Wang, Y., Cohen, J. D., Wong, F., Hasanovic, A., Orr, N., Zhang, M., Popoli, M., McMahon, W., Wood, L. D., Mattox, A., Allaire, C., Segars, J., Williams, C., Tomasetti, C., Boyd, N., Kinzler, K. W., Gilks, C. B., Diaz, L., Wang, T-L., Vogelstein, B., Yong, P. J., Huntsman, D. G. and Shih, I-M. 2017. Cancer-associated mutations in endometriosis without cancer. N. Engl. J. Med. 376, 1835-1848. 

  5. Attar, E., Tokunaga, H., Imir, G., Yilmaz, M. B., Redwine, D., Putman, M., Gurates, B., Attar, R., Yaegashi, N., Hales, D. B. and Bulun, S. E. 2009. Prostaglandin E2 via steroidogenic factor-1 coordinately regulates transcription of steroidogenic genes necessary for estrogen synthesis in endometriosis. J. Clin. Endocrinol. Metab. 94, 623-631. 

  6. Attia, G. R., Zeitoun, K., Edwards, D., Johns, A., Carr, B. R. and Bulun, S. E. 2000. Progesterone receptor isoform A but not B is expressed in endometriosis. J. Clin. Endocrinol. Metab. 85, 2897-2902. 

  7. Barragan, F., Irwin, J. C., Balayan, S., Erikson, D. W., Chen, J. C., Houshdaran, S., Piltonen, T. T., Spitzer, T. L. B., George, A., Rabban, J. T., Nezhat, C. and Giudice, L. C. 2016. Human endometrial fibroblasts derived from mesenchymal progenitors inherit progesterone resistance and acquire an inflammatory phenotype in the endometrial niche in endometriosis. Biol. Reprod. 94, 118. 

  8. Bernardi, L. A., Dyson, M. T., Tokunaga, H., Sison, C., Oral, M., Robins, J. C. and Bulun, S. E. 2019. The essential role of GATA6 in the activation of estrogen synthesis in endometriosis. Reprod. Sci. 26, 60-69. 

  9. Bulun, S. E. 2009. Endometriosis. N. Engl. J. Med. 360, 268-279. 

  10. Bulun, S. E., Cheng, Y. H., Pavone, M. E., Xue, Q., Attar, E., Trukhacheva, E., Tokunaga, H., Utsunomiya, H., Yin, P., Luo, X., Lin, Z., Imir, G., Thung, S., Su, E. J. and Kim, J. J. 2010. Estrogen receptor-beta, estrogen receptor-alpha, and progesterone resistance in endometriosis. Semin. Reprod. Med. 28, 36-43. 

  11. Bulun, S. E., Lin, Z., Imir, G., Amin, S., Demura, M., Yilmaz, B., Martin, R., Utsunomiya, H., Thung, S., Gurates, B., Tamura, M., Langoi, D. and Deb, S. 2005. Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment. Pharmacol. Rev. 57, 359-383. 

  12. Bulun, S. E., Monsavais, D., Pavone, M. E., Dyson, M., Xue, Q., Attar, E., Tokunaga, H. and Su, E. J. 2012. Role of estrogen receptor-beta in endometriosis. Semin. Reprod. Med. 30, 39-45. 

  13. Burney, R. O., Talbi, S., Hamilton, A. E., Vo, K. C., Nyegaard, M., Nezhat, C. R., Lessey, B. A. and Giudice, L. C. 2007. Gene expression analysis of endometrium reveals progesterone resistance and candidate susceptibility genes in women with endometriosis. Endocrinology 148, 3814-3826. 

  14. Caterina, M. J., Leffler, A., Malmberg, A. B., Martin, W. J., Trafton, J., Petersen-Zeitz, K. R., Koltzenburg, M., Basbaum, A. I. and Julius, D. 2000. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 288, 306-313. 

  15. Chabbert-Buffet, N., Meduri, G., Bouchard, P. and Spitz, I. M. 2005. Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applications. Hum. Reprod. Update 11, 293-307. 

  16. Cheng, Y. H., Yin, P., Xue, Q., Yilmaz, B., Dawson, M. I. and Bulun, S. E. 2008. Retinoic acid (RA) regulates 17beta-hydroxysteroid dehydrogenase type 2 expression in endometrium: interaction of RA receptors with specificity protein (SP) 1/SP3 for estradiol metabolism. J. Clin. Endocrinol. Metab. 93, 1915-1923. 

  17. Cho, Y. J., Lee, J. E., Park, M. J., O'Malley, B. W. and Han, S. J. 2018. Bufalin suppresses endometriosis progression by inducing pyroptosis and apoptosis. J. Endocrinol. 237, 255-269. 

  18. Critchley, H. O., Brenner, R. M., Henderson, T. A., Williams, K., Nayak, N. R., Slayden, O. D., Millar, M. R. and Saunders, P. T. 2001. Estrogen receptor beta, but not estrogen receptor alpha, is present in the vascular endothelium of the human and nonhuman primate endometrium. J. Clin. Endocrinol. Metab. 86, 1370-1378. 

  19. Donaghue, C., Westley, B. R. and May, F. E. 1999. Selective promoter usage of the human estrogen receptor-alpha gene and its regulation by estrogen. Mol. Endocrinol. 13, 1934-1950. 

  20. Donnez, J., Hudecek, R., Donnez, O., Matule, D., Arhendt, H. J., Zatik, J., Kasilovskiene, Z., Dumitrascu, M. C., Fernandez, H., Barlow, D. H., Bouchard, P., Fauser, B. C. J. M., Bestel, E., Terrill, P., Osterloh, I. and Loumave, E. 2015. Efficacy and safety of repeated use of ulipristal acetate in uterine fibroids. Fertil. Steril. 103, 519-527. 

  21. Dyson, M. T., Kakinuma, T., Pavone, M. E., Monsivais, D., Navarro, A., Malpani, S. S., Ono, M. and Bulun, S. E. 2015. Aberrant expression and localization of deoxyribonucleic acid methyltransferase 3B in endometriotic stromal cells. Fertil. Steril. 104, 953-963. 

  22. Dyson, M. T., Roqueiro, D., Monsivais, D., Ercan, C. M., Pavone, M. E., Brooks, D. C., Kakinuma, T., Ono, M., Jafari, N., Dai, Y. and Bulun, S. E. 2014. Genome-wide DNA methylation analysis predicts an epigenetic switch for GATA factor expression in endometriosis. PLoS Genet. 10, e1004158. 

  23. Fang, Z., Yang, S., Gurates, B., Tamura, M., Simpson, E., Evans, D. and Bulun, S. E. 2002. Genetic or enzymatic disruption of aromatase inhibits the growth of ectopic uterine tissue. J. Clin. Endocrinol. Metab. 87, 3460-3466. 

  24. Fujimoto, J., Hirose, R., Sakaguchi, H. and Tamaya, T. 1999. Expression of oestrogen receptor-alpha and -beta in ovarian endometriomata. Mol. Hum. Reprod. 5, 742-747. 

  25. Germain, P., Staels, B., Dacquet, C., Spedding, M. and Laudet, V. 2006. Overview of nomenclature of nuclear receptors. Pharmacol. Rev. 58, 685-704. 

  26. Giudice, L. C. and Kao, L. C. 2004. Endometriosis. Lancet 364, 1789-1799. 

  27. Greaves, E., Grieve, K., Horne, A. W. and Saunders, P. T. K. 2014. Elevated peritoneal expression and estrogen regulation of nociceptive ion channels in endometriosis. J. Clin. Endocrinol. Metab. 99, e1738-e1743. 

  28. Greaves, E., Temp, J., Esnal-Zufiurre, A., Mechsner, S., Horne, A. W. and Saunders, P. T. 2015. Estradiol is a critical mediator of macrophage-nerve cross talk in peritoneal endometriosis. Am. J. Pathol. 185, 2286-2297. 

  29. Han, S. J., Hawkins, S. M., Begum, K., Jung, S. Y., Kovanci, E., Qin, J., Lydon, J. P., DeMayo, F. J. and?O'Malley, B. W. 2012. A new isoform of steroid receptor coactivator-1 is crucial for pathogenic progression of endometriosis. Nat. Med. 18, 1102-1111. 

  30. Han, S. J., Jung, S. Y., Wu, S. P., Hawkins, S. M., Park, M. J., Kyo, S., Qin, J., Lydon, J. P., Tsai, S. Y., Tsai, M. J., DeMavo, F. J. and O'Malley, B. W. 2015. Estrogen receptor beta modulates apoptosis complexes and the inflammasome to drive the pathogenesis of endometriosis. Cell 163, 960-974. 

  31. Hsiao, K. Y., Wu, M. H., Chang, N., Yang, S. H., Wu, C. W., Sun, H. S. and Tsai, S. J. 2015. Coordination of AUF1 and miR-148a destabilizes DNA methyltransferase 1 mRNA under hypoxia in endometriosis. Mol. Hum. Reprod. 21, 894-904. 

  32. Huhtinen, K., Stahle, M., Perheentupa, A. and Poutanen, M. 2012. Estrogen biosynthesis and signaling in endometriosis. Mol. Cell. Endocrinol. 358, 146-154. 

  33. Issa, J. P., Ottaviano, Y. L., Celano, P., Hamilton, S. R., Davidson, N. E. and Baylin, S. B. 1994. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat. Genet. 7, 536-540. 

  34. Johnson, N. P. and Hummelshoj, L. 2013. Consensus on current management of endometriosis. Hum. Reprod. 28, 1552-1568. 

  35. Joshi, N. R., Miyadahira, E. H., Afshar, Y., Jeong, J. W., Young, S. L., Lessey, B. A., Serafini, P. C. and Fazleabas, A. T. 2017. Progesterone resistance in endometriosis is modulated by the altered expression of MicroRNA-29c and FKBP4. J. Clin. Endocrinol. Metab. 102, 141-149. 

  36. Kao, L. C., Germeyer, A., Tulac, S., Lobo, S., Yang, J. P., Taylor, R. N., Osteen, K., Lessey, B. A. and Giudice, L. C. 2003. Expression profiling of endometrium from women with endometriosis reveals candidate genes for dis- ease-based implantation failure and infertility. Endocrinology 144, 2870-2881. 

  37. Kastner, P., Krust, A., Turcotte, B., Stropp, U., Tora, L., Gronemeyer, H. and Chambon, P. 1990. Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. EMBO J. 9, 1603-1614. 

  38. Kim, J. J., Kurita, T. and Bulun, S. E. 2013. Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer. Endocr. Rev. 34, 130-162. 

  39. Kokcu, A. 2016. A current view of the role of epigenetic changes in the aetiopathogenesis of endometriosis. J. Obstet. Gynaecol. 36, 153-159. 

  40. Koukoura, O., Sifakis, S. and Spandidos, D. A. 2016. DNA methylation in endometriosis (Review). Mol. Med. Rep. 13, 2939-2948. 

  41. Kulak, J. Jr., Fischer, C., Komm, B. and Taylor, H. S. 2011. Treatment with bazedoxifene, a selective estrogen receptor modulator, causes regression of endometriosis in a mouse model. Endocrinology 152, 3226-3232. 

  42. Kurihara, I., Lee, D. K., Petit, F. G., Jeong, J., Lee, K., Lydon, J. P., DeMayo, F. J., Tsai, M. J. and Tsai, S. Y. 2007. COUP-TFII mediates progesterone regulation of uterine implantation by controlling ER activity. PLoS Genet. 3, e102. 

  43. Kurita, T., Lee, K. J., Cooke, P. S., Lydon, J. P. and Cunha, G. R. 2000. Paracrine regulation of epithelial progesterone receptor and lactoferrin by progesterone in the mouse uterus. Biol. Reprod. 62, 831-838. 

  44. Li, X., Large, M. J., Creighton, C. J., Lanz, R. B., Jeong, J. W., Young, S. L., Lessey, B. A., Palomino, W. A., Tsai,?S. Y. and Demayo, F. J. 2013. COUP-TFII regulates human endometrial stromal genes involved in inflammation. Mol. Endocrinol. 27, 2041-2054. 

  45. Liang, B., Wu, L., Xu, H., Cheung, C. W., Fung, W. Y., Wong, S. W. and Wang, C. C. 2018. Efficacy, safety and recurrence of new progestins and selective progesterone receptor modulator for the treatment of endometriosis: a comparison study in mice. Reprod. Biol. Endocrinol. 16, 32. 

  46. Lin, B. C., Suzawa, M., Blind, R. D., Tobias, S. C., Bulun, S. E., Scanlan, T. S. and Ingraham, H. A. 2009. Stimulating the GPR30 estrogen receptor with a novel tamoxifen analogue activates SF-1 and promotes endometrial cell proliferation. Cancer Res. 69, 5415-5423. 

  47. Lin, S. C., Li, Y. H., Wu, M. H., Chang, Y. F., Lee, D. K., Tsai, S. Y., Tsai, M. J. and Tsai, S. J. 2014. Suppression of COUP-TFII by proinflammatory cytokines contributes to the pathogenesis of endometriosis. J. Clin. Endocrinol. Metab. 99, e427-e437. 

  48. Lin, Z., Reierstad, S., Huang, C. C. and Bulun, S. E. 2007. Novel estrogen receptor-alpha binding sites and estradiol target genes identified by chromatin immunoprecipitation cloning in breast cancer. Cancer Res. 67, 5017-5024. 

  49. Madauss, K. P., Stewart, E. L. and Williams, S. P. 2007. The evolution of progesterone receptor ligands. Med. Res. Rev. 27, 374-400. 

  50. Matsuzaki, S., Murakami, T., Uehara, S., Canis, M., Sasano, H. and Okamura, K. 2001. Expression of estrogen receptor alpha and beta in peritoneal and ovarian endometriosis. Fertil. Steril. 75, 1198-1205. 

  51. Mei, L., Bao, J., Tang, L., Zhang, C., Wang, H., Sun, L., Ma, G., Huang, L., Yang, J., Zhang, L., Liu, K., Song, C. and Sun, H. 2010. A novel mifepristone-loaded implant for long-term treatment of endometriosis: in vitro and in vivo studies. Eur. J. Pharm. Sci. 39, 421-427. 

  52. Milingos, S., Protopapas, A., Drakakis, P., Liapi, A., Loutradis, D., Kallipolitis, G., Milingos, D. and Michalas, S. 2003. Laparoscopic management of patients with endometriosis and chronic pelvic pain. Ann. N. Y. Acad. Sci. 997, 269-273. 

  53. Monsivais, D., Dyson, M. T., Yin, P., Coon, J. S., Navarro, A., Feng, G., Malpani, S. S., Ono, M., Ercan, C. M., Wei, J. J., Pavone, M. E., Su, E. and Bulun, S. E. 2014. ERbeta- and prostaglandin E2-regulated pathways integrate cell proliferation via Ras-like and estrogen-regulated growth in- hibitor in endometriosis. Mol. Endocrinol. 28, 1304-1315. 

  54. Monsivais, D., Dyson, M. T., Yin, P., Navarro, A., Coon, J. S. T., Pavone, M. E. and Bulun, S. E. 2016. Estrogen receptor beta regulates endometriotic cell survival through serum and glucocorticoid-regulated kinase activation. Fertil. Steril. 105, 1266-1273. 

  55. Montgomery, G. W., Nyholt, D. R., Zhao, Z. Z., Treloar, S. A., Painter, J. N., Missmer, S. A., Kennedy, S. H. and Zondervan, K. T. 2008. The search for genes contributing to endometriosis risk. Hum. Reprod. Update 14, 447-457. 

  56. Mosselman, S., Polman, J. and Dijkema, R. 1996. ER beta: identification and characterization of a novel human estrogen receptor. FEBS Lett. 392, 49-53. 

  57. Mote, P. A., Balleine, R. L., McGowan, E. M. and Clarke, C. L. 1999. Colocalization of progesterone receptors A and B by dual immunofluorescent histochemistry in human endometrium during the menstrual cycle. J. Clin. Endocrinol. Metab. 84, 2963-2971. 

  58. Mulac-Jericevic, B., Lydon, J. P., DeMayo, F. J. and Conneely, O. M. 2003. Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform. Proc. Natl. Acad. Sci. 100, 9744-9749. 

  59. Mulac-Jericevic, B., Mullinax, R. A., DeMayo, F. J., Lydon, J. P. and Conneely, O. M. 2000. Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform. Science 289, 1751-1754. 

  60. Naqvi, H., Sakr, S., Presti, T., Krikun, G., Komm, B. and Taylor, H. S. 2014. Treatment with bazedoxifene and conjugated estrogens results in regression of endometriosis in a murine model. Biol. Reprod. 90, 121. 

  61. Noble, L. S., Takayama, K., Zeitoun, K. M., Putman, J. M., Johns, D. A., Hinshelwood, M. M., Agarwal, V. R., Zhao, Y., Carr, B. R. and Bulun, S. E. 1997. Prostaglandin E2 stimulates aromatase expression in endometriosis-derived stromal cells. J. Clin. Endocrinol. Metab. 82, 600-606. 

  62. Ottaviano, Y. L., Issa, J. P., Parl, F. F., Smith, H. S., Baylin, S. B. and Davidson, N. E. 1994. Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells. Cancer Res. 54, 2552-2555. 

  63. Pavone, M. E., Dyson, M., Reirstad, S., Pearson, E., Ishikawa, H., Cheng, Y. H. and Bulun, S. E. 2011. Endometriosis expresses a molecular pattern consistent with decreased retinoid uptake, metabolism and action. Hum. Reprod. 26, 2157-2164. 

  64. Pavone, M. E., Reierstad, S., Sun, H., Milad, M., Bulun, S. E. and Cheng, Y. H. 2010. Altered retinoid uptake and action contributes to cell survival in endometriosis. J. Clin. Endocrinol. Metab. 95, e300-e309. 

  65. Pei, T., Liu, C., Liu, T., Xiao, L., Luo, B., Tan, J., Li, X., Zhou, G., Duan, C. and Huang, W. 2018. miR-194-3p represses the progesterone receptor and decidualization in eutopic endometrium from women with endometriosis. Endocrinology 159, 2554-2562. 

  66. Rahmioglu, N., Missmer, S. A., Montgomery, G. W. and Zondervan, K. T. 2012. Insights into assessing the genetics of endometriosis. Curr. Obstet. Gynecol. Rep. 1, 124-137. 

  67. Rizner, T. L. 2016. The important roles of steroid sulfatase and sulfotransferases in gynecological diseases. Front. Pharmacol. 7, 30. 

  68. Shang, Y. 2006. Molecular mechanisms of oestrogen and SERMs in endometrial carcinogenesis. Nat. Rev. Cancer 6, 360-368. 

  69. Sirianni, R., Chimento, A., De Luca, A., Zolea, F., Carpino, A., Rago, V., Maggiolini, M., Ando, S. and Pezzi, V. 2009. Inhibition of cyclooxygenase-2 down-regulates aromatase activity and decreases proliferation of Leydig tumor cells. J. Biol. Chem. 284, 28905-28916. 

  70. Smuc, T., Pucelj, M. R., Sinkovec, J., Husen, B., Thole, H. and Lanisnik Rizner, T. 2007. Expression analysis of the genes involved in estradiol and progesterone action in human ovarian endometriosis. Gynecol. Endocrinol. 23, 105-111. 

  71. Soysal, S., Soysal, M. E., Ozer, S., Gul, N. and Gezgin, T. 2004. The effects of post-surgical administration of goserelin plus anastrozole compared to goserelin alone in patients with severe endometriosis: a prospective randomized trial. Hum. Reprod. 19, 160-167. 

  72. Sun, H. S., Hsiao, K. Y., Hsu, C. C., Wu, M. H. and Tsai, S. J. 2003. Transactivation of steroidogenic acute regulatory protein in human endometriotic stromalcells is mediated by the prostaglandin EP2 receptor. Endocrinology 144, 3934-3942. 

  73. Tamura, M., Deb, S., Sebastian, S., Okamura, K. and Bulun, S. E. 2004. Estrogen up-regulates cyclooxygenase-2 via estrogen receptor in human uterine microvascular endothelial cells. Fertil. Steril. 81, 1351-1356. 

  74. Tamura, M., Sebastian, S., Yang, S., Gurates, B., Fang, Z. and Bulun, S. E. 2002. Interleukin-1beta elevates cyclooxygenase-2 protein level and enzyme activity via increasing its mRNA stability in human endometrial stromal cells: an effect mediated by extracellularly regulated kin- ases 1 and 2. J. Clin. Endocrinol. Metab. 87, 3263-3273. 

  75. Trukhacheva, E., Lin, Z., Reierstad, S., Cheng, Y. H., Milad, M. and Bulun, S. E. 2009. Estrogen receptor (ER) beta regulates ERalpha expression in stromal cells derived from ovarian endometriosis. J. Clin. Endocrinol. Metab. 94, 615-622. 

  76. van Kaam, K. J. A. F., Delvoux, B., Romano, A., D'Hooghe, T., Dunselman, G. A. and Groothuis, P. G. 2011. Deoxyribonucleic acid methyltransferases and methyl-CpG-binding domain proteins in human endometrium and endometriosis. Fertil. Steril. 95, 1421-1427. 

  77. Vegeto, E., Shahbaz, M. M., Wen, D. X., Goldman, M. E., O'Malley, B. W. and McDonnell, D. P. 1993. Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function. Mol. Endocrinol. 7, 1244-1255. 

  78. Vercellini, P., Eskenazi, B., Consonni, D., Somigliana, E., Parazzini, F., Abbiati, A. and Fedele, L. 2011. Oral contraceptives and risk of endometriosis: a systematic review and meta-analysis. Hum. Reprod. Update 17, 159-170. 

  79. Vercellini, P., Vigano, P., Somigliana, E. and Fedele, L. 2014. Endometriosis: pathogenesis and treatment. Nat. Rev. Endocrinol. 10, 261-275. 

  80. Whitaker, L. H. R., Williams, A. R. W. and Critchley, H. O. D. 2014. Selective progesterone receptor modulators. Curr. Opin. Obstet. Gynecol. 26, 237-242. 

  81. Wu, M. H., Wang, C. A., Lin, C. C., Chen, L. C., Chang, W. C. and Tsai, S. J. 2005. Distinct regulation of cyclooxygenase-2 by interleukin-1beta in normal and endometriotic stromal cells. J. Clin. Endocrinol. Metab. 90, 286-295. 

  82. Wu, Y., Starzinski-Powitz, A. and Guo, S. W. 2008. Prolonged stimulation with tumor necrosis factor-alpha induced partial methylation at PR-B promoter in immortalized epithelial-like endometriotic cells. Fertil. Steril. 90, 234-237. 

  83. Wu, Y., Strawn, E., Basir, Z., Halverson, G. and Guo, S. W. 2006. Promoter hypermethylation of progesterone receptor isoform B (PR-B) in endometriosis. Epigenetics 1, 106-111. 

  84. Xue, Q., Lin, Z., Cheng, Y-H., Huang, C-C., Marsh, E., Yin, P., Milad, M. P., Confino, E., Reierstad, S., Innes, J. and Bulun, S. E. 2007. Promoter methylation regulates estrogen receptor 2 in human endometrium and endometriosis. Biol. Reprod. 77, 681-687. 

  85. Yang, H., Kang, K., Cheng, C., Mamillapalli, R. and Taylor, H. S. 2015. Integrative analysis reveals regulatory programs in endometriosis. Reprod. Sci. 22, 1060-1072. 

  86. Yang, H., Zhou, Y., Edelshain, B., Schatz, F., Lockwood, C. J. and Taylor, H. S. 2012. FKBP4 is regulated by HOXA10 during decidualization and in endometriosis. Reproduction 143, 531-538. 

  87. Yang, S., Thiel, K. W. and Leslie, K. K. 2011. Progesterone: the ultimate endometrial tumor suppressor. Trends Endocrinol. Metab. 22, 145-152. 

  88. Yilmaz, B. D. and Bulun, S. E. 2019. Endometriosis and nuclear receptors. Hum. Reprod. Update 25, 473-485. 

  89. Yin, H., Lo, J. H., Kim, J. Y., Marsh, E. E., Kim, J. J., Ghosh, A. K., Bulun, S. and Chakravarti, D. 2013. Expression profiling of nuclear receptors identifies key roles of NR4A subfamily in uterine fibroids. Mol. Endocrinol. 27, 726-740. 

  90. Zeitoun, K., Takayama, K., Michael, M. D. and Bulun, S. E. 1999. Stimulation of aromatase P450 promoter (II) activity in endometriosis and its inhibition in endometrium are regulated by competitive binding of steroidogenic factor-1 and chicken ovalbumin upstream promoter transcription factor to the same cis-acting element. Mol. Endocrinol. 13, 239-253. 

  91. Zhao, Y., Gong, P., Chen, Y., Nwachukwu, J. C., Sriniva- san, S., Ko, C., Bagchi, M. K., Taylor, R. N., Korach, K. S., Nettles, K. W., Katzenellenbogen, J. A. and Katzenellenbogen, B. S. 2015. Dual suppression of estrogenic and inflammatory activities for targeting of endometriosis. Sci. Transl. Med. 7, 271-279. 

  92. Zhou, M., Fu, J., Xiao, L., Yang, S., Song, Y., Zhang, X., Feng, X., Sun, H., Xu, W. and Huang, W. 2016. miR-196a overexpression activates the MEK/ERK signal and represses the progesterone receptor and decidualization in eutopic endometrium from women with endometriosis. Hum. Reprod. 31, 2598-2608. 

관련 콘텐츠

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로